For fit myeloma patients being planned for HDCT/ASCT, chemotherapy such as with cyclophosphamide together with G-CSF or a strategy with G-CSF alone are commonly used for peripheral stem cell mobilization [9, 10, 29]. Here, CSF3 is linked to plasma cell myeloma.